{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:56:12Z","timestamp":1769838972544,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.yrtph.2015.01.013","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T10:45:41Z","timestamp":1423305941000},"page":"515-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Use of read-across and computer-based predictive analysis for the safety assessment of PEG cocamines"],"prefix":"10.1016","volume":"71","author":[{"given":"Julie A.","family":"Skare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengde","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Duche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Ringeissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald L.","family":"Bjerke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viny","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Eisenmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2015.01.013_b0005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/10915819309141598","article-title":"Final report on the safety assessment of polyethylene glycols (PEGs)-6, -8, -32, -75, -150, -14M, and -20M","volume":"12","author":"Andersen","year":"1993","journal-title":"J. Am. Coll. Toxicol."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2015.01.013_b0010","first-page":"43","article-title":"Final report on the safety assessment of PEG-2, -3, -5, -10, -15, and -20 cocamine","volume":"18","author":"Andersen","year":"1999","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2015.01.013_b0015","first-page":"S1","article-title":"A safety assessment of branched chain saturated alcohols when used as fragrance ingredients","volume":"48","author":"Belsito","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2015.01.013_b0020","first-page":"S1","article-title":"A safety assessment of noncyclic alcohols with unsaturated branched chain when used as fragrance ingredients","volume":"48","author":"Belsito","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2015.01.013_b0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.yrtph.2014.01.004","article-title":"A framework to facilitate consistent characterization of read-across uncertainty","volume":"68","author":"Blackburn","year":"2014","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.yrtph.2015.01.013_b0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.yrtph.2011.03.002","article-title":"Case studies to test: a framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments","volume":"60","author":"Blackburn","year":"2011","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.yrtph.2015.01.013_b0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11743-002-0208-y","article-title":"Novel hydroperoxides as primary autoxidation products of a model ethoxylated surfactant","volume":"5","author":"Bodin","year":"2002","journal-title":"J. Surfactants Deterg."},{"key":"10.1016\/j.yrtph.2015.01.013_b0040","first-page":"287","article-title":"Isosterism and bioisosterism in drug design","volume":"37","author":"Burger","year":"1991","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.yrtph.2015.01.013_b0045","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0192623309352496","article-title":"A strategy for risk management of drug-induced phospholipidosis","volume":"37","author":"Chatman","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2015.01.013_b0050","unstructured":"CIR Expert Panel, 2010. Final Report of the Cosmetic Ingredient Review Expert Panel. Amended Safety Assessment of Triethylene Glycol and Polyethylene Glycols (PEGs)-4, -6, -7, -8, -9, -10, -12, -14, -16, -18, -20, -32, -33, -40, -45, -55, -60, -75, -80, -90, -100, -135, -150, -180, -200, -220, -240, -350, -400, -450, -500, -800, -2M, -5M, -7M, -9M, -14M, -20M, -23M, 25M, -45M, 65M, -90M, -115M, -160M, and any PEGs\u2a7e4 as used in Cosmetics. <http:\/\/online.personalcarecouncil.org\/ctfa-static\/online\/lists\/cir-pdfs\/FR548.pdf> (accessed 29.06.2014)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0055","series-title":"Designing Safer Chemicals, ACS Symposium Series 640","first-page":"16","article-title":"General principles for the design of safer chemicals: toxicological considerations for chemists","author":"DeVito","year":"1996"},{"key":"10.1016\/j.yrtph.2015.01.013_b0060","unstructured":"EG&G Mason Research Institute, 1980a. Salmonella\/Mammalian-Microsome Mutagenesis Assay (Ames Test). Unpublished Report (No. 003-692-420-1)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0065","unstructured":"EG&G Mason Research Institute, 1980b. Test for Chemical Induction of Mutation in Mammalian Cells in Culture \u2013 The L5179Y TK+\/\u2212 Mouse Lymphoma Assay. Unpublished Report (No. 003-692-420-7)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0070","unstructured":"EG&G Mason Research Institute, 1981a. Salmonella\/Mammalian-Microsome Mutagenesis Assay (Ames Test). Unpublished Report (No. 003-468-677-1)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0075","unstructured":"EG&G Mason Research Institute, 1981b. Salmonella\/Mammalian-Microsome Mutagenesis Assay (Ames Test). Unpublished Report (No. 003-407-637-1)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0080","unstructured":"EG&G Mason Research Institute, 1982. In Vivo Cytogenetics Study in Rats. Unpublished Report (No. MRI-182-PG-82-58)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0085","unstructured":"Federal Register, 2010. 75(81), 22234\u201322240."},{"key":"10.1016\/j.yrtph.2015.01.013_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/019262339502300104","article-title":"Comparative 90-day feeding study with low-viscosity white mineral oil in Fischer 344 and Sprague\u2013Dawley-derived CRL:CD rats","volume":"23","author":"Firriolo","year":"1995","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2015.01.013_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2005.06.001","article-title":"Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products","volume":"214","author":"Fruijtier-P\u00d6lloth","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2015.01.013_b0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-6264(70)80385-6","article-title":"Summary of toxicological data \u2013 acute oral toxicity and short term feeding studies on polyoxyethylene tallow amine in rats and dogs","volume":"8","author":"Goater","year":"1970","journal-title":"Food Cosmet. Toxicol."},{"key":"10.1016\/j.yrtph.2015.01.013_b0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0045-6535(97)00365-2","article-title":"Toxicity of aliphatic amines: structure\u2013activity relationship","volume":"36","author":"Greim","year":"1998","journal-title":"Chemosphere"},{"key":"10.1016\/j.yrtph.2015.01.013_b0110","unstructured":"Hazleton Laboratories Europe, Ltd., 1982a. 13 Week Oral (Dietary) Toxicity Study in the Rat: ECM BTS 306, E1095.01. Unpublished Report (No. 2913-110\/369)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0115","unstructured":"Hazleton Laboratories Europe, Ltd., 1982b. A 4Week Percutaneous Toxicity Study in the Rabbit, ECM BTS 306. Unpublished Report (No. 2827-110\/366)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0120","unstructured":"Huntingdon Research Centre Plc, 1984. Micronucleus Test on E-2352.01 (ECM BTS 902\/01 Tamet). Unpublished Report (No. P+G 1114\/84560)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0125","unstructured":"Interdepartmental Group on Health Risks from Chemicals, 2006. Guidelines on route-to-route extrapolation of toxicity data when assessing health risks of chemicals. <http:\/\/www.silsoe.cranfield.ac.uk\/ieh\/ighrc\/ighrc.html>."},{"key":"10.1016\/j.yrtph.2015.01.013_b0130","unstructured":"Laboratory of Mathematical Chemistry. <http:\/\/oasis-lmc.org\/products\/models\/human-health-endpoints\/skin-sensitization.aspx>."},{"key":"10.1016\/j.yrtph.2015.01.013_b0135","unstructured":"Lhasa Ltd. <http:\/\/archive-org.com\/org\/l\/lhasalimited.org\/2012-12-28_1081910_18\/Lhasa_Limited_Uses_and_benefits_of_Derek_Nexus\/>."},{"key":"10.1016\/j.yrtph.2015.01.013_b0140","unstructured":"Microbiological Associates, Inc., 1982. Cytogenicity Study \u2013 Chinese Hamster Ovary (CHO) Cells In Vitro. Unpublished Report (No. T1807.338)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0145","series-title":"International Cosmetic Ingredient Dictionary and Handbook","year":"2014"},{"key":"10.1016\/j.yrtph.2015.01.013_b0150","unstructured":"OECD, 2014. Guidance on Grouping of Chemicals, second ed., Series on Testing and Assessment No. 194."},{"key":"10.1016\/j.yrtph.2015.01.013_b0155","unstructured":"Raltech Scientific Services. Subchronic 28-day dermal toxicity study of B0254\u201301 in rabbits. Unpublished report (No. 277723 \u2013 Study 80513) (1980)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0160","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.yrtph.2015.01.013_b0165","unstructured":"Scientific Committee on Consumer Safety, 2012. The SCCS\u2019s Notes of Guidance for the Testing of Cosmetic Substances and Their Safety Evaluation. 8th Revision."},{"key":"10.1016\/j.yrtph.2015.01.013_b0170","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0278-6915(97)00105-1","article-title":"Lack of carcinogenicity of medium-viscosity liquid paraffin given in the diet to F344 rats","volume":"35","author":"Shoda","year":"1997","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2015.01.013_b0175","unstructured":"The Procter & Gamble Company, 1980. Subchronic Percutaneous Toxicity Study (28-Day). Unpublished Report (No. BSBTS 593S; YE-252-B)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0180","unstructured":"The Procter & Gamble Company, 1983. Unscheduled DNA Synthesis Assay in Primary Cultures of Rat Hepatocytes. Unpublished Report (No. M0021)."},{"key":"10.1016\/j.yrtph.2015.01.013_b0190","unstructured":"US EPA HPV, 2003. \u201cFND Ether Amines Category HPV Chemicals Challenge \u2013 Appendix A Robust Summaries for Reliable Studies\u201d, EPA Document ID 201-14978. <http:\/\/www.epa.gov\/chemrtk\/pubs\/summaries\/amines\/c14171tc.htm>."},{"key":"10.1016\/j.yrtph.2015.01.013_b0185","unstructured":"US EPA, 2009. Alkyl Amine Polyethoxylates. Human Health Risk Assessment to Support Proposed Exemption from Requirement of a Tolerance When Used as Inert Ingredients in Pesticide Formulations."},{"key":"10.1016\/j.yrtph.2015.01.013_b0195","unstructured":"US EPA, 2010. Phosphate Ester, Tallowamine Ethoxylated. Human Health Risk Assessment to Support Proposed Exemption from Requirement of a Tolerance When Used as Inert Ingredients in Pesticide Formulations."},{"key":"10.1016\/j.yrtph.2015.01.013_b0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/dmd.106.012419","article-title":"PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies","volume":"35","author":"Webster","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2015.01.013_b0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yrtph.2009.09.006","article-title":"A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments","volume":"56","author":"Wu","year":"2010","journal-title":"Regul. Toxicol. Pharm."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323001500015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323001500015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T07:54:08Z","timestamp":1537862048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323001500015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S027323001500015X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.01.013","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of read-across and computer-based predictive analysis for the safety assessment of PEG cocamines","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}